RxDoctor Payments Data

Crystal Cooper

Primary Care · Shenandoah, TXNPI 1609566413

Payments from drug & device makers

$2,036in general payments, 2019–2025

Across 106 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$421
  • Lilly USA, LLC$349
  • Corcept Therapeutics$181
  • AbbVie$148
  • Radius Health, Inc.$119
  • Averitas Pharma Inc.$75
  • plus $743 from 20 others

What the payments were for

  • Food & beverage$2,036100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,036 in reported general payments places this provider in the 85th percentile of 563 primary care providers in Texas.

See all primary care providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide229$304,048
MounjaroTirzepatide158$205,033
RybelsusSemaglutide28$40,566
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/734$35,741
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog45$35,570
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog38$29,976
TrulicityDulaglutide13$29,314
JardianceEmpagliflozin17$24,193
Fiasp FlextouchInsulin Aspart (Niacinamide)30$22,546
Soliqua 100-33Insulin Glargine/Lixisenatide23$21,939
Humalog Kwikpen U-100Insulin Lispro55$16,320
Lantus SolostarInsulin Glargine,hum.Rec.Anlog80$15,059
Janumet XrSitagliptin Phos/Metformin Hcl16$14,521
Tresiba Flextouch U-100Insulin Degludec25$14,326
Bydureon BciseExenatide Microspheres15$11,866

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Novolog$421$351,875272 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog$349$238,759201 claims
Boehringer IngelheimJardiance$68$24,19317 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$69$21,93923 claims
AbbVieSynthroid$148$3,64547 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$45$2,066204 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 563 primary care providers in Texas.

Other primary care in Shenandoah

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →